MONDRIX Trademark

Trademark Overview


On Thursday, July 16, 2009, a trademark application was filed for MONDRIX with the United States Patent and Trademark Office. The USPTO has given the MONDRIX trademark a serial number of 77782969. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 3, 2017. This trademark is owned by GlaxoSmithKline Biologicals S.A.. The MONDRIX trademark is filed in the Pharmaceutical Products category with the following description:

vaccines for human use
mondrix

General Information


Serial Number77782969
Word MarkMONDRIX
Filing DateThursday, July 16, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 3, 2017
Registration Number3809555
Registration DateTuesday, June 29, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2010

Trademark Statements


Goods and Servicesvaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 3, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Friday, February 3, 2017CANCELLED SEC. 8 (6-YR)
Monday, June 29, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 8, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 7, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 7, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 29, 2010REGISTERED-PRINCIPAL REGISTER
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 13, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2010PUBLISHED FOR OPPOSITION
Wednesday, March 10, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 8, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 5, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 5, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 5, 2010TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, December 8, 2009NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, December 8, 2009FINAL REFUSAL E-MAILED
Tuesday, December 8, 2009FINAL REFUSAL WRITTEN
Wednesday, November 18, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 18, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 18, 2009ASSIGNED TO LIE
Friday, November 6, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, October 18, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, October 18, 2009NON-FINAL ACTION E-MAILED
Sunday, October 18, 2009NON-FINAL ACTION WRITTEN
Friday, October 16, 2009ASSIGNED TO EXAMINER
Monday, July 20, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 20, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords


mondrix human vaccines